Literature DB >> 7468425

Primary pulmonary hypertension: beneficial therapy with diltiazem.

H Kambara, K Fujimoto, A Wakabayashi, C Kawai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7468425     DOI: 10.1016/0002-8703(81)90672-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  11 in total

Review 1.  Cor pulmonale in cystic fibrosis.

Authors:  M H Götz; O C Burghuber; U Salzer-Muhar; W Wolosczuk; M Weissel; E Hartter
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

2.  The treatment of primary pulmonary hypertension.

Authors:  N G Uren; C M Oakley
Journal:  Br Heart J       Date:  1991-08

Review 3.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

Authors:  M M Buckley; S M Grant; K L Goa; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

4.  Severe pulmonary hypertension in a patient with rheumatoid arthritis--response to nifedipine.

Authors:  S G Lehrman; R C Hollander
Journal:  West J Med       Date:  1986-08

5.  Management of primary pulmonary hypertension.

Authors:  C M Oakley
Journal:  Br Heart J       Date:  1985-01

6.  Immediate and long-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.

Authors:  C A Visser; W Jaarsma; G Kan; J J Koolen; K I Lie
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 7.  Drug treatment of primary pulmonary hypertension.

Authors:  A A McLeod; D E Jewitt
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

8.  Verapamil in primary pulmonary hypertension.

Authors:  I Malcić; D Richter
Journal:  Br Heart J       Date:  1985-03

9.  Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.

Authors:  T Takahashi; T Kanda; S Imai; T Suzuki; I Kobayashi; K Murata
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

10.  Hazards of diazoxide in pulmonary hypertension.

Authors:  J Buch; A Wennevold
Journal:  Br Heart J       Date:  1981-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.